Sector Chart Gan & Lee Pharmaceuticals.

603087

CNE100003ZH1

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Biopharmaceuticals

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E
GAN & LEE PHARMACEUTICALS.	5.39B
REGENERON PHARMACEUTICALS, INC.	74.51B
CSL LIMITED	58.22B
UCB	53.6B
SAMSUNG BIOLOGICS CO.,LTD.	52.43B
BIOGEN INC.	26.05B

End-of-day quote Shanghai S.E. Other stock markets 10/12/2025			5-day change	1st Jan Change
64.02 ^CNY	+0.95%		+3.34%	+45.17%

12-09	Gan & Lee Pharmaceuticals Gets Clinical Trial Approval For Atopic Dermatitis Drug	MT
11-18	Gan & Lee Pharmaceuticals Europe GmbH Announces Committee for Medicinal Products for Human Use of the European Medicines Agency Recommends the Approval of Insulin Glargine Injection	CI

Sector Chart Gan & Lee Pharmaceuticals.

Equities

603087

CNE100003ZH1

Pharmaceuticals

Sector Biopharmaceuticals